Logo image of XPER

XPERI INC (XPER) Stock Fundamental Analysis

NYSE:XPER - New York Stock Exchange, Inc. - US98423J1016 - Common Stock - Currency: USD

8.1  +0.08 (+1%)

After market: 8.1 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to XPER. XPER was compared to 284 industry peers in the Software industry. Both the profitability and financial health of XPER have multiple concerns. XPER is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

XPER had positive earnings in the past year.
In the past year XPER has reported a negative cash flow from operations.
In the past 5 years XPER always reported negative net income.
XPER had negative operating cash flow in 4 of the past 5 years.
XPER Yearly Net Income VS EBIT VS OCF VS FCFXPER Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.10%, XPER is in line with its industry, outperforming 59.86% of the companies in the same industry.
XPER has a better Return On Equity (-3.26%) than 60.92% of its industry peers.
Industry RankSector Rank
ROA -2.1%
ROE -3.26%
ROIC N/A
ROA(3y)-41.72%
ROA(5y)-29.98%
ROE(3y)-66.84%
ROE(5y)-46.08%
ROIC(3y)N/A
ROIC(5y)N/A
XPER Yearly ROA, ROE, ROICXPER Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

XPER has a Gross Margin of 76.96%. This is in the better half of the industry: XPER outperforms 73.59% of its industry peers.
XPER's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for XPER so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y-4.34%
XPER Yearly Profit, Operating, Gross MarginsXPER Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

XPER does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, XPER has more shares outstanding
XPER has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, XPER has a worse debt to assets ratio.
XPER Yearly Shares OutstandingXPER Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
XPER Yearly Total Debt VS Total AssetsXPER Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

XPER has an Altman-Z score of -0.30. This is a bad value and indicates that XPER is not financially healthy and even has some risk of bankruptcy.
XPER has a Altman-Z score of -0.30. This is in the lower half of the industry: XPER underperforms 70.77% of its industry peers.
XPER has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of XPER (0.12) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z -0.3
ROIC/WACCN/A
WACC10.67%
XPER Yearly LT Debt VS Equity VS FCFXPER Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.64 indicates that XPER should not have too much problems paying its short term obligations.
XPER has a Current ratio (1.64) which is in line with its industry peers.
XPER has a Quick Ratio of 1.64. This is a normal value and indicates that XPER is financially healthy and should not expect problems in meeting its short term obligations.
XPER has a Quick ratio (1.64) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
XPER Yearly Current Assets VS Current LiabilitesXPER Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1172.73% over the past year.
Measured over the past years, XPER shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.24% on average per year.
The Revenue has decreased by -5.30% in the past year.
XPER shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.04% yearly.
EPS 1Y (TTM)1172.73%
EPS 3Y-21.82%
EPS 5Y-21.24%
EPS Q2Q%420%
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y0.49%
Revenue growth 5Y20.04%
Sales Q2Q%-4.05%

3.2 Future

XPER is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.97% yearly.
XPER is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.33% yearly.
EPS Next Y-5.57%
EPS Next 2Y9.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.39%
Revenue Next 2Y3.33%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
XPER Yearly Revenue VS EstimatesXPER Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
XPER Yearly EPS VS EstimatesXPER Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

XPER is valuated cheaply with a Price/Earnings ratio of 6.86.
Based on the Price/Earnings ratio, XPER is valued cheaply inside the industry as 94.72% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of XPER to the average of the S&P500 Index (24.21), we can say XPER is valued rather cheaply.
The Price/Forward Earnings ratio is 6.91, which indicates a rather cheap valuation of XPER.
Based on the Price/Forward Earnings ratio, XPER is valued cheaper than 95.07% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.44. XPER is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.86
Fwd PE 6.91
XPER Price Earnings VS Forward Price EarningsXPER Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XPER Per share dataXPER EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.97%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for XPER!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XPERI INC

NYSE:XPER (5/9/2025, 8:28:16 PM)

After market: 8.1 0 (0%)

8.1

+0.08 (+1%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners91.55%
Inst Owner Change-1.09%
Ins Owners2.11%
Ins Owner Change13.84%
Market Cap368.71M
Analysts84
Price Target18.61 (129.75%)
Short Float %2.91%
Short Ratio3.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)122.3%
Min EPS beat(2)63.17%
Max EPS beat(2)181.42%
EPS beat(4)3
Avg EPS beat(4)69.25%
Min EPS beat(4)-33.78%
Max EPS beat(4)181.42%
EPS beat(8)7
Avg EPS beat(8)68.94%
EPS beat(12)11
Avg EPS beat(12)63.7%
EPS beat(16)14
Avg EPS beat(16)54.69%
Revenue beat(2)0
Avg Revenue beat(2)-1.75%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-0.34%
Revenue beat(4)0
Avg Revenue beat(4)-4.6%
Min Revenue beat(4)-10.31%
Max Revenue beat(4)-0.34%
Revenue beat(8)0
Avg Revenue beat(8)-3.49%
Revenue beat(12)1
Avg Revenue beat(12)-10.79%
Revenue beat(16)1
Avg Revenue beat(16)-19.32%
PT rev (1m)0%
PT rev (3m)-2.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-86.13%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.34%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)-3.59%
Valuation
Industry RankSector Rank
PE 6.86
Fwd PE 6.91
P/S 0.75
P/FCF N/A
P/OCF N/A
P/B 0.86
P/tB 1.39
EV/EBITDA N/A
EPS(TTM)1.18
EY14.57%
EPS(NY)1.17
Fwd EY14.48%
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-1.22
OCFYN/A
SpS10.85
BVpS9.43
TBVpS5.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.1%
ROE -3.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.96%
FCFM N/A
ROA(3y)-41.72%
ROA(5y)-29.98%
ROE(3y)-66.84%
ROE(5y)-46.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y-4.34%
F-Score3
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.27%
Cap/Sales 3.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z -0.3
F-Score3
WACC10.67%
ROIC/WACCN/A
Cap/Depr(3y)21.67%
Cap/Depr(5y)15.65%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1172.73%
EPS 3Y-21.82%
EPS 5Y-21.24%
EPS Q2Q%420%
EPS Next Y-5.57%
EPS Next 2Y9.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y0.49%
Revenue growth 5Y20.04%
Sales Q2Q%-4.05%
Revenue Next Year-1.39%
Revenue Next 2Y3.33%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year744.52%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-461.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-89358.1%
OCF growth 3YN/A
OCF growth 5YN/A